Healthcare software solutions group Equasens reports sales of €53.3 million for the first three months of 2024, down 5.2% on a reported basis and 6.7% on a like-for-like basis.

The contribution of external growth offsets the base effect of Segur," says the company, adding that its equipment marketing divisions are heavily impacted by the economic situation.

Equasens is maintaining its forecasts, predicting a slight upturn in growth from the second half of 2024, followed by a significant acceleration from 2025. It is also continuing to invest, and remains open to external growth opportunities.

Copyright (c) 2024 CercleFinance.com. All rights reserved.